- Herbalife agreed to acquire certain assets from Bioniq, a UK-based personalized supplements company.
- The deal is expected to close in Q2 2026, subject to customary closing conditions.
- Purchase price is USD 55 million to be paid over five years, including an initial USD 10 million payment at closing.
- Transaction value also includes up to USD 95 million in contingent payments tied to future performance.
- Herbalife also obtained a call option to acquire Bioniq LAB, a separate platform focused on small molecules and peptides.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Herbalife Ltd. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260326423343) on March 26, 2026, and is solely responsible for the information contained therein.
Comments